– Data presented at ASCO annual meeting demonstrate 55% Disease Control Rate (DCR) in heavily…
IRVINE, Calif., June 02, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today…
NEW YORK–(BUSINESS WIRE)–Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology,…
— VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet…
SAN FRANCISCO–(BUSINESS WIRE)–SoFi Technologies, Inc. (NASDAQ: SOFI), the digital personal finance company, today announced plans…
Achieves record revenue, GAAP and non-GAAP earnings, cash flow from operations and free cash flow…
HB-200 in combination with pembrolizumab doubled the objective response rate of 1st-line pembrolizumab for patients…
HB-200 in combination with pembrolizumab doubled the objective response rate of 1st-line pembrolizumab for patients…
She will remain a member of the COMPASS Pathways Board of Directors LONDON, May 31,…
She will remain a member of the COMPASS Pathways Board of Directors LONDON, May 31,…
FORT WORTH, Texas–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming…
Osage County Native youth encouraged to embrace healthy hobbies and activities HOMINY, Okla.–(BUSINESS WIRE)–The Association…
Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the…
LONDON, May 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
LONDON, May 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
More than half of the patients demonstrated remission of depression at 18 months, after a…
71% objective response rate, with 59% of patients achieving a very good partial response or…
71% objective response rate, with 59% of patients achieving a very good partial response or…
Data demonstrate objective response rates from 56% to 63% across three independent cohorts of advanced…
Data demonstrate objective response rates from 56% to 63% across three independent cohorts of advanced…